Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
SAYSVFN motif domain containing 1 (SAYSD1) is a protein-coding gene primarily involved in cellular protein quality control mechanisms. Specifically, it acts as a *reader* of UFM1-modified proteins, recognizing and binding to ufmylated ribosomes when a ribosome becomes stalled during protein translation. SAYSD1 promotes the transport of these stalled nascent chains via the TRAPP complex to lysosomes for degradation, contributing to the clearance of defective proteins and stalled translation products. This protein is predominantly located in intracellular, membrane-bounded organelles and is active at the endoplasmic reticulum. While mutations or changes in SAYSD1 have been noted to be associated with corpus luteum cysts, its direct therapeutic relevance, interacting drugs, biomarker status, or recognized safety concerns are not established in current literature[1][11][12].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on SAYSVFN motif domain containing 1 (SAYSD1).